๐€๐ง๐ญ๐ข๐œ๐ก๐จ๐ฅ๐ข๐งะต๐ซ๐ ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ, ๐’๐ข๐ณ๐ž ๐ญ๐จ 2024-2032

๐‘๐ž๐š๐ ๐ฆ๐จ๐ซ๐ž: https://www.reportsandinsights.....com/report/antichol

Size

The global anticholinะตrgic drugs market was valued at US$ 345.6 Million in 2024 and is expected to register a CAGR of 6.1% over the forecast period and reach US$ 588.9 Million in 2033.